T-Cell Immunotherapy Market Research Report by Region (Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
T-Cell Immunotherapy Market Research Report by Region (Europe, Asia Pacific, North America and South America), Type and Application, Forecast to 2028 (Updated Version Available)
ID : MRI47951 | Date : Feb, 2021 | Pages :
180 | Region : Global |
Publisher : 99 Strategy
The T-Cell Immunotherapy market report provides a detailed analysis of global market size, value chain optimization, segmentation market growth, market share, competitive Landscape, regional and country-level market size, sales analysis, impact of domestic and global market players, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global T-Cell Immunotherapy market size is expected to gain market growth in the forecast period of 2023 to 2028, with a CAGR of xx%% in the forecast period of 2023 to 2028 and will expected to reach USD xx million by 2028, from USD xx million in 2020.
Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.
Competitive Landscape and T-Cell Immunotherapy Market Share Analysis
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Product Type Coverage (Market Size Forecast, Major Company of Product Type etc.):
CAR-T
TCR
TIL Therapies
By Application
Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
T-Cell Immunotherapy competitive landscape provides details by vendors, including company overview, company total revenue (financial), market potential, global presence, T-Cell Immunotherapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the T-Cell Immunotherapy sales, revenue and market share for each player covered in this report.
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global T-Cell Immunotherapy market presented in the report. This section sheds light on the sales growth of different regional and country-level T-Cell Immunotherapy markets. For the historical and forecast period 2015 to 2028, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global T-Cell Immunotherapy market.
Region Coverage (Regional Production, Demand Forecast by Countries etc.): North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East Africa (Saudi Arabia, South Africa etc.)
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the T-Cell Immunotherapy market for the forecast period 2023 - 2028?
• What are the driving forces in the T-Cell Immunotherapy market for the forecast period 2023 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the T-Cell Immunotherapy industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe T-Cell Immunotherapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe T-Cell Immunotherapy Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.2 America Market Size and Growth
Figure America T-Cell Immunotherapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America T-Cell Immunotherapy Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia T-Cell Immunotherapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaT-Cell Immunotherapy Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania T-Cell Immunotherapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania T-Cell Immunotherapy Market Forecast and Growth Rate, 2021-2026(Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa T-Cell Immunotherapy Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa T-Cell Immunotherapy Market Forecast and Growth Rate, 2021-2026(Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global T-Cell Immunotherapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global T-Cell Immunotherapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global T-Cell Immunotherapy Revenue by Type, 2015-2020 (Million USD)
Figure Global T-Cell Immunotherapy Revenue Share by Type in 2020 (Million USD)
Table Global T-Cell Immunotherapy Production Volume by Type, 2015-2020 (Volume)
Figure Global T-Cell Immunotherapy Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global T-Cell Immunotherapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global T-Cell Immunotherapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Global T-Cell Immunotherapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global T-Cell Immunotherapy Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global T-Cell Immunotherapy Consumption Value by Region, 2015-2020 (Million USD)
Table Global T-Cell Immunotherapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe T-Cell Immunotherapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe T-Cell Immunotherapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe T-Cell Immunotherapy Revenue by Type, 2015-2020 (Million USD)
Figure Europe T-Cell Immunotherapy Revenue Share by Type in 2020 (Million USD)
Table Europe T-Cell Immunotherapy Production Volume by Type, 2015-2020 (Volume)
Figure Europe T-Cell Immunotherapy Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe T-Cell Immunotherapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe T-Cell Immunotherapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe T-Cell Immunotherapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe T-Cell Immunotherapy Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe T-Cell Immunotherapy Consumption Value by Region, 2015-2020 (Million USD)
Table Europe T-Cell Immunotherapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America T-Cell Immunotherapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America T-Cell Immunotherapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America T-Cell Immunotherapy Revenue by Type, 2015-2020 (Million USD)
Figure America T-Cell Immunotherapy Revenue Share by Type in 2020 (Million USD)
Table America T-Cell Immunotherapy Production Volume by Type, 2015-2020 (Volume)
Figure America T-Cell Immunotherapy Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America T-Cell Immunotherapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America T-Cell Immunotherapy Consumption Value Share by End-Use in 2020 (Million USD)
Table America T-Cell Immunotherapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America T-Cell Immunotherapy Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America T-Cell Immunotherapy Consumption Value by Region, 2015-2020 (Million USD)
Table America T-Cell Immunotherapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia T-Cell Immunotherapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia T-Cell Immunotherapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia T-Cell Immunotherapy Revenue by Type, 2015-2020 (Million USD)
Figure Asia T-Cell Immunotherapy Revenue Share by Type in 2020 (Million USD)
Table Asia T-Cell Immunotherapy Production Volume by Type, 2015-2020 (Volume)
Figure Asia T-Cell Immunotherapy Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia T-Cell Immunotherapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia T-Cell Immunotherapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia T-Cell Immunotherapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia T-Cell Immunotherapy Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia T-Cell Immunotherapy Consumption Value by Region, 2015-2020 (Million USD)
Table Asia T-Cell Immunotherapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania T-Cell Immunotherapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania T-Cell Immunotherapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania T-Cell Immunotherapy Revenue by Type, 2015-2020 (Million USD)
Figure Oceania T-Cell Immunotherapy Revenue Share by Type in 2020 (Million USD)
Table Oceania T-Cell Immunotherapy Production Volume by Type, 2015-2020 (Volume)
Figure Oceania T-Cell Immunotherapy Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania T-Cell Immunotherapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania T-Cell Immunotherapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania T-Cell Immunotherapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania T-Cell Immunotherapy Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania T-Cell Immunotherapy Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania T-Cell Immunotherapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa T-Cell Immunotherapy Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa T-Cell Immunotherapy Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa T-Cell Immunotherapy Revenue by Type, 2015-2020 (Million USD)
Figure Africa T-Cell Immunotherapy Revenue Share by Type in 2020 (Million USD)
Table Africa T-Cell Immunotherapy Production Volume by Type, 2015-2020 (Volume)
Figure Africa T-Cell Immunotherapy Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa T-Cell Immunotherapy Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa T-Cell Immunotherapy Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa T-Cell Immunotherapy Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa T-Cell Immunotherapy Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa T-Cell Immunotherapy Consumption Value by Region, 2015-2020 (Million USD)
Table Africa T-Cell Immunotherapy Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global T-Cell Immunotherapy Production Forecast
Figure Global T-Cell Immunotherapy Revenue and Growth Rate Forecast 2021-2026(Million USD)
Figure Global T-Cell Immunotherapy Production Volume and Growth Rate Forecast 2021-2026(Volume)
8.2 Global T-Cell Immunotherapy Forecast by Type
Table Global T-Cell Immunotherapy Revenue by Type, 2021-2026(Million USD)
Figure Global T-Cell Immunotherapy Revenue Share by Type in 2026 (Million USD)
Table Global T-Cell Immunotherapy Production Volume by Type, 2021-2026(Volume)
Figure Global T-Cell Immunotherapy Production Volume Share by Type in 2026 (Volume)
8.3 Global T-Cell Immunotherapy Forecast by End-Use (2021E-2026F)
Table Global T-Cell Immunotherapy Consumption Value by End-Use, 2021-2026(Million USD)
Figure Global T-Cell Immunotherapy Consumption Value Share by End-Use in 2026 (Million USD)
Table Global T-Cell Immunotherapy Consumption Volume by End-Use, 2021-2026(Volume)
8.4 Global T-Cell Immunotherapy Forecast by Region (2021E-2026F)
Table Global T-Cell Immunotherapy Consumption Value by Region, 2021-2026(Million USD)
Figure Global T-Cell Immunotherapy Consumption Value Share by Region in 2026 (Million USD)
Table Global T-Cell Immunotherapy Consumption Volume by Region, 2021-2026(Volume)
Figure Global T-Cell Immunotherapy Consumption Volume Share by Region in 2026 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Adaptimmune
9.1.1 Adaptimmune Profile
Table Adaptimmune Overview List
9.1.2 Adaptimmune Products & Services
9.1.3 Adaptimmune Company Dynamics & News
9.1.4 Adaptimmune Business Operation Conditions
Table Business Operation of Adaptimmune (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 Altor Bioscience Corporation
9.2.1 Altor Bioscience Corporation Profile
Table Altor Bioscience Corporation Overview List
9.2.2 Altor Bioscience Corporation Products & Services
9.2.3 Altor Bioscience Corporation Company Dynamics & News
9.2.4 Altor Bioscience Corporation Business Operation Conditions
Table Business Operation of Altor Bioscience Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Cellectis
9.3.1 Cellectis Profile
Table Cellectis Overview List
9.3.2 Cellectis Products & Services
9.3.3 Cellectis Company Dynamics & News
9.3.4 Cellectis Business Operation Conditions
Table Business Operation of Cellectis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Juno Therapeutics
9.4.1 Juno Therapeutics Profile
Table Juno Therapeutics Overview List
9.4.2 Juno Therapeutics Products & Services
9.4.3 Juno Therapeutics Company Dynamics & News
9.4.4 Juno Therapeutics Business Operation Conditions
Table Business Operation of Juno Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Kite Pharma
9.5.1 Kite Pharma Profile
Table Kite Pharma Overview List
9.5.2 Kite Pharma Products & Services
9.5.3 Kite Pharma Company Dynamics & News
9.5.4 Kite Pharma Business Operation Conditions
Table Business Operation of Kite Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 Novartis
9.6.1 Novartis Profile
Table Novartis Overview List
9.6.2 Novartis Products & Services
9.6.3 Novartis Company Dynamics & News
9.6.4 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Takara Bio
9.7.1 Takara Bio Profile
Table Takara Bio Overview List
9.7.2 Takara Bio Products & Services
9.7.3 Takara Bio Company Dynamics & News
9.7.4 Takara Bio Business Operation Conditions
Table Business Operation of Takara Bio (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Unum Therapeutics
9.8.1 Unum Therapeutics Profile
Table Unum Therapeutics Overview List
9.8.2 Unum Therapeutics Products & Services
9.8.3 Unum Therapeutics Company Dynamics & News
9.8.4 Unum Therapeutics Business Operation Conditions
Table Business Operation of Unum Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global T-Cell Immunotherapy Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global T-Cell Immunotherapy Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global T-Cell Immunotherapy Sales Volume by Companies, 2015-2020E (Volume)
Table Global T-Cell Immunotherapy Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe T-Cell Immunotherapy Market Concentration Ratio in 2020E
Figure America T-Cell Immunotherapy Market Concentration Ratio in 2020E
Figure Asia T-Cell Immunotherapy Market Concentration Ratio in 2020E
Figure Oceania T-Cell Immunotherapy Market Concentration Ratio in 2020E
Figure Africa T-Cell Immunotherapy Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON T-Cell Immunotherapy INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 T-Cell Immunotherapy INDUSTRY SUMMARY & CONCLUSION
Research Methodology
The Market Reports Insights offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.
Market Reports Insights are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.
The Company's Research Process Has the Following Advantages:
Information Procurement
The step comprises the procurement of market-related information or data via different methodologies & sources.
Information Investigation
This step comprises the mapping and investigation of all the information procured from the earlier step. It also includes the analysis of data differences observed across numerous data sources.
Highly Authentic Source
We offer highly authentic information from numerous sources. To fulfills the client’s requirement.
Market Formulation
This step entails the placement of data points at suitable market spaces in an effort to assume possible conclusions. Analyst viewpoint and subject matter specialist based examining the form of market sizing also plays an essential role in this step.
Validation & Publishing of Information
Validation is a significant step in the procedure. Validation via an intricately designed procedure assists us to conclude data-points to be used for final calculations.
Well researched, expertise analysts, well organized, concrete and current topics delivered in time.
- President and CEO
Very helpful to understand overview of business status, by customers, categories, timeless, and regions. Able to build the future business strategy on the basis of research report. Validated and researched information of reports.
- Senior Manager, Product Development
We are very thankful to (company name) for detailed research report delivering in short period of time. Good market research Company really commendable.
- Senior Manager, Product Development
Excellent services, unique and very professional. The effort taken to make sure relevance to our requirements ensured the best possible outcome.
